ArticleJournal of orthopaedic research : official publication of the Orthopaedic Research Society2026
Localized Delivery of a Small Molecule Hedgehog Agonist via Poly(ε-caprolactone) Scaffolds Enhances Tendon-to-Bone Integration.
Article in Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Localized Delivery of a Small Molecule Hedgehog Agonist via Poly(ε-caprolactone) Scaffolds Enhances Tendon-to-Bone Integration.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Tendon and ligament injuries often require surgery, with successful recovery, whether direct repair of a torn tendon to bone or reconstruction of ligaments, requiring effective tendon-to-bone integration. Unfortunately, re-tear rates can be high, demonstrating the need for improved treatment strategies. The Hedgehog (Hh) pathway is critical to fibrocartilage formation at tendon and ligament insertion sites during development, and recent studies indicate that it promotes tendon-to-bone integration post-surgery. However, systemic delivery of Hh signaling agonists can result in off-target effects. In this study, we developed a scaffold system for local delivery of a Hh signaling agonist (SAG) to promote tendon-to-bone integration. We fabricated aligned electrospun scaffolds loaded with four concentrations of SAG and quantified the fiber alignment and diameter, which were not different between the different concentrations. We then measured the in vitro release profile and found a dose-dependent release of SAG from the scaffolds, as measured by expression of the downstream Hh target gene, Gli1, in bone marrow stromal cell cultures that received conditioned media. Finally, we combined the scaffolds with tendon grafts and inserted them into bone tunnels created in the proximal tibiae of mice. SAG released from the scaffolds did not affect cell infiltration in the graft or scaffold, but increased expression of Gli1 by cells in the bone tunnels while also increasing mineralized fibrocartilage formation in a dose-dependent manner. These findings indicate that scaffold-mediated local delivery of SAG can effectively enhance tendon-to-bone integration, offering a promising strategy for treating tendon and ligament injuries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.